- Investing Ideas
- Global Pharmaceuticals & Biotech High Risk Large Caps
Global Pharmaceuticals & Biotech High Risk Large Caps
Results
6
Are you holding one of these? A list of some of the most volatile large-cap stocks over the past five years.
6 companies
Natera
Market Cap: US$27.7b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$200.09
7D
1.2%
1Y
30.1%
BioNTech
Market Cap: US$21.4b
Engages in the development and commercialization of immunotherapies in Germany.
BNTX
US$88.41
7D
-2.4%
1Y
-12.2%
Illumina
Market Cap: US$19.0b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$123.79
7D
3.8%
1Y
40.6%
Sam Chun Dang Pharm
Market Cap: ₩21.9t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩941,000.00
7D
28.9%
1Y
389.8%
Regencell Bioscience Holdings
Market Cap: US$13.5b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$25.22
7D
11.2%
1Y
2,237.0%
Elanco Animal Health
Market Cap: US$11.9b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$24.44
7D
4.4%
1Y
128.6%